IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Neurology in Texas

In 2025 Q1–Q4, the provider or facility offer prevailed in 90.8% of 3,184 determined Federal IDR dispute line items for neurology in Texas. The median prevailing offer was 65.87x the QPA (25th–75th percentile 22.89x–125.96x; n = 3,022). The median time to a decision was 32 business days (n = 3,184).

Determined line items

3,184

2025 Q1–Q4 · 2 split decisions excluded

Provider win rate

90.8%

n = 3,184 · 2025 Q1–Q4

Median payment vs QPA

65.87x †

middle half 22.89x–125.96x · n = 3,022 · 2025 Q1–Q4

Median days to decision

32

business days, from dispute initiation · n = 3,184 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q43,18490.8%65.87x †22.89x–125.96x3,02232
2024 Q1–Q44,96391.9%14.82x2.46x–55.82x4,32259
2023 Q1–Q415489.6%5.66x1.38x–38.58x15250
2023 Q1–2025 Q48,30191.4%33.35x †3.55x–90.71x7,496not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
95938 Placement of skin electrodes and measurement of stimulated sites on arms and leg48789.1%147.61x †46632
95937 Testing of nerve-muscle junction47992.3%94.47x †46134
95941 Continuous remote monitoring of nervous system during operation, each hour41893.5%33.10x †39531.5
95955 Measurement of brain wave activity (EEG) outside the brain during surgery32895.7%160.63x †31031.5
95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities30089.0%61.46x †28530
95939 Placement of skin electrodes and measurement of central motor stimulation in arm23388.8%54.32x †21830
95868 Needle measurement of electrical activity in muscles on both sides of body9888.8%84.05x †9532
95957 Measurement of brain wave activity (EEG), digital analysis9380.6%22.92x †9330
95886 Needle measurement of electrical activity in arm or leg muscles, complete study8989.9%44.79x †8232
95870 Needle measurement of electrical activity in arm, leg, trunk or head muscles, li8491.7%190.72x †8233
95865 Needle measurement of electrical activity in voice box muscles7994.9%55.90x †7629
95907 Nerve conduction, 1-2 studies7095.7%38.90x †6835.5
95908 Nerve conduction, 3-4 studies5991.5%37.80x †5932
95887 Needle measurement of electrical activity in trunk or head muscles4895.8%84.23x †4627.5
51785 Needle measurement and recording of electrical activity of muscles at bladder an3193.5%–2833

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Texas · Neurology in all states

FAQ

What is the Federal IDR provider win rate for neurology in Texas?

In 2025 Q1–Q4, the provider or facility offer was selected in 90.8% of 3,184 determined dispute line items for neurology in Texas. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for neurology in Texas?

In 2025 Q1–Q4, the median prevailing offer was 65.87x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 22.89x to 125.96x (n = 3,022 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for neurology in Texas?

In 2025 Q1–Q4, the median was 32 business days (n = 3,184 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR